Expression of the SARS-CoV-2 receptor-binding domain by live attenuated influenza vaccine virus as a strategy for designing a bivalent vaccine against COVID-19 and influenza.
Stepanova E, Isakova-Sivak I, Mezhenskaya D, Niskanen S, Matyushenko V, Bazhenova E, Rak A, Wong PF, Prokopenko P, Kotomina T, Krutikova E, Legotskiy S, Neterebskii B, Ostroukhova T, Sivak K, Orshanskaya Y, Yakovlev K, Rudenko L.
Stepanova E, et al. Among authors: isakova sivak i.
Virol J. 2024 Apr 9;21(1):82. doi: 10.1186/s12985-024-02350-w.
Virol J. 2024.
PMID: 38589848
Free PMC article.